HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Domingo M. Braile Max Schaldach Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braile, D. M. Articles by Schaldach, M. Search for Related Content PubMed PubMed Citation Articles by Braile, D. M. Articles by Schaldach, M.

Ann Thorac Surg 2000;69:1445-1447
© 2000 The Society of Thoracic Surgeons

---

Original articles: Cardiovascular

Dynamic cardiomyoplasty: long-term clinical results in patients with dilated cardiomyopathy

^a Faculdade de Medicina de São José do Rio Preto-Medical School FAMERP,São Paulo, Brazil
^b Hospital Beneficência Portuguesa de São José do Rio Preto, São Paulo, Brazil

Address reprint requests to Dr Braile, Av Juscelino Kubitschek 3101, 15091-450, São José do Rio Preto, São Paulo, Brazil
e-mail: domingo{at}braile.com.br

Background. Dynamic cardiomyoplasty has been considered to be an effective method of surgical treatment of patients with end-stage heart failure, and is an alternative to heart transplantation.

Methods. We critically evaluated the long-term course of 52 patients with dilated cardiomyopathy who underwent dynamic cardiomyoplasty and were followed-up for up to 110 months.

Results. Dilated cardiomyopathy was due to undetermined cause in 42 patients (80.8%), Chagas disease in 8 (15.4%), viral infection in 1 (1.9%), and peripartum cardiomyopathy in 1 (1.9%). In the nonchagasic group the survival rates were 79.5% ± 6.1%, 67.8% ± 7.1%, 53.7% ± 8.3%, 49.9% ± 8.3%, 14.9% ± 12.2%, and 14.9% ± 12.2%, respectively, at 12, 24, 48, 60, 80 and 110 months of follow-up. In the chagasic patients the survival rates were 37.5% ± 17.1%, 12.5% ± 11.7%, 12.5% ± 11.7% and 0%, respectively, at 12, 24, 48, and 60 months of follow-up, making chagasic cardiomyopathy a possible contraindication for dynamic cardiomyoplasty.

Conclusions. There was no correlation between the clinical improvement and hemodynamic data. Ventricular fibrillation was a frequent cause of immediate and late death, suggesting the need for prophylactic use of antiarrhythmic drugs or implantable cardioverter/defibrillators.

This article has been cited by other articles:

				K. Minami Surgical Treatments for Endstage Heart Failure Due to Dilated Cardiomyopathy Asian Cardiovasc Thorac Ann, September 1, 2001; 9(3): 159 - 166. [Full Text] [PDF]